Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-24-000199

Director sold 1,020 shares at $30.00 ($30,600)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
SATO VICKI L Director 2024-09-13 Sale 10b5-1 −1,020 $30.00 $30,600 115,156 D
Open-market sales · 1,020 sh · avg $30.00 · $30,600
Loading xslF345X05/wk-form4_1726517865.xml…